The FDA Is Not Too Strict on Rare Disease Drugs, But It's Getting There
The FDA released a new rare disease drug framework the same week advocates staged a funeral protest outside its doors. That timing tells you everything about where the agency actually stands.
By Maya Okafor · 3 min read